Copyright Reports & Markets. All rights reserved.

Global Biosynthesis of Cannabinoids Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Biosynthesis of Cannabinoids
  • 1.2 Classification of Biosynthesis of Cannabinoids by Type
    • 1.2.1 Overview: Global Biosynthesis of Cannabinoids Market Size by Type: 2024 Versus 2030
    • 1.2.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Type in 2030
    • 1.2.3 THC
    • 1.2.4 CBD
    • 1.2.5 Others
  • 1.3 Global Biosynthesis of Cannabinoids Market by Application
    • 1.3.1 Overview: Global Biosynthesis of Cannabinoids Market Size by Application: 2024 Versus 2030
    • 1.3.2 Food Industry
    • 1.3.3 Medical Industry
    • 1.3.4 Others
  • 1.4 Global Biosynthesis of Cannabinoids Market Size & Forecast
  • 1.5 Market Drivers, Restraints and Trends
    • 1.5.1 Biosynthesis of Cannabinoids Market Drivers
    • 1.5.2 Biosynthesis of Cannabinoids Market Restraints
    • 1.5.3 Biosynthesis of Cannabinoids Trends Analysis

2 Company Profiles

  • 2.1 Anandia Laboratories
    • 2.1.1 Anandia Laboratories Details
    • 2.1.2 Anandia Laboratories Major Business
    • 2.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Product and Solutions
    • 2.1.4 Anandia Laboratories Recent Developments and Future Plans
  • 2.2 Gingko Bioworks
    • 2.2.1 Gingko Bioworks Details
    • 2.2.2 Gingko Bioworks Major Business
    • 2.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Product and Solutions
    • 2.2.4 Gingko Bioworks Recent Developments and Future Plans
  • 2.3 Hyasynth Bio
    • 2.3.1 Hyasynth Bio Details
    • 2.3.2 Hyasynth Bio Major Business
    • 2.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Product and Solutions
    • 2.3.4 Hyasynth Bio Recent Developments and Future Plans
  • 2.4 InMed Pharmaceuticals
    • 2.4.1 InMed Pharmaceuticals Details
    • 2.4.2 InMed Pharmaceuticals Major Business
    • 2.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
    • 2.4.4 InMed Pharmaceuticals Recent Developments and Future Plans
  • 2.5 Librede
    • 2.5.1 Librede Details
    • 2.5.2 Librede Major Business
    • 2.5.3 Librede Biosynthesis of Cannabinoids Product and Solutions
    • 2.5.4 Librede Recent Developments and Future Plans
  • 2.6 Renew Biopharma
    • 2.6.1 Renew Biopharma Details
    • 2.6.2 Renew Biopharma Major Business
    • 2.6.3 Renew Biopharma Biosynthesis of Cannabinoids Product and Solutions
    • 2.6.4 Renew Biopharma Recent Developments and Future Plans
  • 2.7 Cronos Group
    • 2.7.1 Cronos Group Details
    • 2.7.2 Cronos Group Major Business
    • 2.7.3 Cronos Group Biosynthesis of Cannabinoids Product and Solutions
    • 2.7.4 Cronos Group Recent Developments and Future Plans
  • 2.8 Organigram
    • 2.8.1 Organigram Details
    • 2.8.2 Organigram Major Business
    • 2.8.3 Organigram Biosynthesis of Cannabinoids Product and Solutions
    • 2.8.4 Organigram Recent Developments and Future Plans
  • 2.9 Teewinot Life Sciences
    • 2.9.1 Teewinot Life Sciences Details
    • 2.9.2 Teewinot Life Sciences Major Business
    • 2.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Product and Solutions
    • 2.9.4 Teewinot Life Sciences Recent Developments and Future Plans
  • 2.10 ICC International Cannabis Corp.
    • 2.10.1 ICC International Cannabis Corp. Details
    • 2.10.2 ICC International Cannabis Corp. Major Business
    • 2.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product and Solutions
    • 2.10.4 ICC International Cannabis Corp. Recent Developments and Future Plans
  • 2.11 Biotii Technologies Corp.
    • 2.11.1 Biotii Technologies Corp. Details
    • 2.11.2 Biotii Technologies Corp. Major Business
    • 2.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Product and Solutions
    • 2.11.4 Biotii Technologies Corp. Recent Developments and Future Plans
  • 2.12 Bristol-Myers Squibb
    • 2.12.1 Bristol-Myers Squibb Details
    • 2.12.2 Bristol-Myers Squibb Major Business
    • 2.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Product and Solutions
    • 2.12.4 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.13 Biogen Inc.
    • 2.13.1 Biogen Inc. Details
    • 2.13.2 Biogen Inc. Major Business
    • 2.13.3 Biogen Inc. Biosynthesis of Cannabinoids Product and Solutions
    • 2.13.4 Biogen Inc. Recent Developments and Future Plans
  • 2.14 GW Pharmaceuticals
    • 2.14.1 GW Pharmaceuticals Details
    • 2.14.2 GW Pharmaceuticals Major Business
    • 2.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
    • 2.14.4 GW Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biosynthesis of Cannabinoids Revenue and Share by Players (2024 & 2030)
  • 3.2 Biosynthesis of Cannabinoids Players Head Office, Products and Services Provided
  • 3.3 Biosynthesis of Cannabinoids Mergers & Acquisitions
  • 3.4 Biosynthesis of Cannabinoids New Entrants and Expansion Plans

4 Global Biosynthesis of Cannabinoids Forecast by Region

  • 4.1 Global Biosynthesis of Cannabinoids Market Size by Region: 2024 VS 2030
  • 4.2 Global Biosynthesis of Cannabinoids Market Size by Region, (2024-2030)
  • 4.3 North America
    • 4.3.1 Key Companies of Biosynthesis of Cannabinoids in North America
    • 4.3.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in North America
    • 4.3.3 North America Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
  • 4.4 Europe
    • 4.4.1 Key Companies of Biosynthesis of Cannabinoids in Europe
    • 4.4.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Europe
    • 4.4.3 Europe Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
  • 4.5 Asia-Pacific
    • 4.5.1 Key Companies of Biosynthesis of Cannabinoids in Asia-Pacific
    • 4.5.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Asia-Pacific
    • 4.5.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
    • 4.5.4 China
    • 4.5.5 Japan
    • 4.5.6 South Korea
  • 4.6 South America
    • 4.6.1 Key Companies of Biosynthesis of Cannabinoids in South America
    • 4.6.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in South America
    • 4.6.3 South America Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)
  • 4.7 Middle East & Africa
    • 4.7.1 Key Companies of Biosynthesis of Cannabinoids in Middle East & Africa
    • 4.7.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Middle East & Africa
    • 4.7.3 Middle East & Africa Biosynthesis of Cannabinoids Market Size and Prospect (2024-2030)

5 Market Size Segment by Type

  • 5.1 Global Biosynthesis of Cannabinoids Market Forecast by Type (2024-2030)
  • 5.2 Global Biosynthesis of Cannabinoids Market Share Forecast by Type (2024-2030)

6 Market Size Segment by Application

  • 6.1 Global Biosynthesis of Cannabinoids Market Forecast by Application (2024-2030)
  • 6.2 Global Biosynthesis of Cannabinoids Market Share Forecast by Application (2024-2030)

7 Research Findings and Conclusion

    8 Appendix

    • 8.1 Methodology
    • 8.2 Research Process and Data Source

    According to our latest research, the global Biosynthesis of Cannabinoids market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.
    Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
    The Biosynthesis of Cannabinoids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
    Market segmentation
    Biosynthesis of Cannabinoids market is split by Type and by Application. For the period 2024-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type, covers
    THC
    CBD
    Others
    Market segment by Application, can be divided into
    Food Industry
    Medical Industry
    Others
    Market segment by players, this report covers
    Anandia Laboratories
    Gingko Bioworks
    Hyasynth Bio
    InMed Pharmaceuticals
    Librede
    Renew Biopharma
    Cronos Group
    Organigram
    Teewinot Life Sciences
    ICC International Cannabis Corp.
    Biotii Technologies Corp.
    Bristol-Myers Squibb
    Biogen Inc.
    GW Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America
    Europe
    Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
    South America
    Middle East & Africa
    The content of the study subjects, includes a total of 8 chapters:
    Chapter 1, to describe Biosynthesis of Cannabinoids product scope, market overview, market opportunities, market driving force and market risks.
    Chapter 2, to profile the top players of Biosynthesis of Cannabinoids, with recent developments and future plans
    Chapter 3, the Biosynthesis of Cannabinoids competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4, to break the market size data at the region level, with key companies in the key region and Biosynthesis of Cannabinoids market forecast, by regions, with revenue, from 2024 to 2030.
    Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2024 to 2030.
    Chapter 7 and 8, to describe Biosynthesis of Cannabinoids research findings and conclusion, appendix and data source.

    Buy now